Alkermes plc. Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31)
Alkermes plc. (ALKS) reported Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) of $372.00 thousand for the 12-month period ending 2012-03-31, per its 10-K filed 2012-05-18.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesTax · last filed 2012-05-18
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $173.00K.
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$3.00K.
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2011-03-31 was -$30.00K.
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2010-12-31 was -$304.00K.
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2012 was $372.00K, a 65.33% increase from fiscal 2011.
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2011 was $225.00K, a 87.71% decline from fiscal 2010.
- Alkermes plc. other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2010 was $1.83M.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-18 | $170.00K derived: sum of 2 quarters · filed 2012-05-18 | $372.00K 10-K · filed 2012-05-18 | |
| 2011-12-31 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | $199.00K 10-Q · filed 2012-02-02 | ||
| 2011-09-30 | $202.00K 10-Q · filed 2011-11-03 | |||
| 2011-03-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-18 | -$334.00K derived: sum of 2 quarters · filed 2012-05-18 | $225.00K 10-K · filed 2012-05-18 | |
| 2010-12-31 | -$304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | $255.00K 10-Q · filed 2012-02-02 | ||
| 2010-09-30 | $559.00K 10-Q · filed 2011-11-03 | |||
| 2010-03-31 | $1.83M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |